CAMBRIDGE, Mass., May 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will hold its Annual Meeting of Stockholders on June 14, 2011 at 10:30 a.m. EDT at the offices of WilmerHale, LLP, 60 State Street, Boston, MA 02109. Stockholders of record at the close of business on April 18, 2011 are entitled to vote at the Annual Meeting. Momenta mailed a notice of the Annual Meeting and related proxy materials to stockholders of record on or about May 11, 2011.
About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Momenta was founded in 2001 based on technology initially developed at Massachusetts Institute of Technology and is headquartered in Cambridge, MA.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trade names and service marks are the property of Momenta Pharmaceuticals, Inc. Other trademarks or service marks appearing in this press release are the property of their respective owners and are not the property of Momenta Pharmaceuticals, Inc. or its subsidiaries.
CONTACT: Beverly Holley Momenta Pharmaceuticals, Inc. bholley@momentapharma.com 617-395-5189